BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35039060)

  • 21. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
    Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
    Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J
    J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA DICER1-AS1 promotes colorectal cancer progression by activating the MAPK/ERK signaling pathway through sponging miR-650.
    Li W; Ke C; Yang C; Li J; Chen Q; Xia Z; Xu J
    Cancer Med; 2023 Apr; 12(7):8351-8366. PubMed ID: 36708020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.
    Qian S; Lin S; Xu X; Bai H; Yeerken A; Ying X; Li Z; Fei X; Yang J; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2022 Sep; 14(1):111. PubMed ID: 36064442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
    Dai W; Zeng W; Lee D
    J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
    Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
    Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYC-Activated LncRNA
    Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
    Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
    Li Q; Jiang B; Qi Y; Zhang H; Ma H
    Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m
    Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
    Hong S; Yan Z; Song Y; Bi M; Li S
    Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

  • 34. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
    Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
    Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLCO4A1-AS1 regulates laryngeal squamous cell carcinoma cell phenotypes via the Wnt pathway.
    Zhang F; Mao D; He Z; Li W; Zhang X; Li L
    Oral Dis; 2023 Mar; 29(2):390-401. PubMed ID: 33914996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
    Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.
    Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y
    Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
    Li C; Wang P; Du J; Chen J; Liu W; Ye K
    IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
    Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
    Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
    Huang W; Tian Y; Dong S; Cha Y; Li J; Guo X; Yuan X
    Oncol Rep; 2017 Sep; 38(3):1402-1410. PubMed ID: 28731158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.